A recent paper by Syed et al. demonstrates that mutations in the Nucleocapsid (N) protein, one of the four structural proteins in SARS-CoV-2 in addition to the Spike protein, plays a critical role in the increased transmission and possibly virulence of…
Another advance in the field of regenerative medicine as researchers at the MIT Media Lab develop a new surgical framework that helps amputees retain a richer sense of awareness over their residual limb.
Another advance in the field of regenerative medicine as researchers at the MIT Media Lab develop a new surgical framework that helps amputees retain a richer sense of awareness over their residual limb.
As the CMMI embarks on a quest to improve Medicaid it may need to consider adjusting criteria of what counts as a successful alternative payment model. Sometimes cost savings may not be achievable. Improved health outcomes may be a more realistic goal,…
Thanks to the work of scientists from the University Miguel Hernandez, we are now further along the way to restoring vision for the fully blind.
Tuberculosis and neglected tropical diseases have been negatively impacted by the Covid-19 pandemic, as resources have been diverted to the Covid-19 response. This has caused an acute disruption of activities aimed at disease diagnosis, control, and el…
The potential mutagenic effects of molnupiravir on the SARS-CoV-2 virus itself are a danger to population health, and a glaring blindspot for the review committees involved.
A new large-scale study from Israel demonstrates a third Pfizer dose reduced Covid-related hospitalization by 93 percent, Covid-related death by 81 percent, and severe Covid-19 illness by 92 percent, compared with receiving just two doses.
Novavax’s recent application for licensing its Covid-19 vaccine in Australia, Canada, and the UK hasn’t gained much traction in the US media. This is odd, given that the vaccine could not only help to close the equity gap in vaccine supply globally, bu…
Democrats have revived drug pricing reform with a narrow set of proposed measures. What’s being hammered out by Democrats as part of the budget reconciliation bill is much less ambitious than, say, H.R 3. Nevertheless, any reform of drug pricing, howev…
